Kestra Advisory Services, LLC Gilead Sciences, Inc. Transaction History

Kestra Advisory Services, LLC

$17.6 Billion
Q2 2024

A detailed history of Kestra Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 94,187 shares of GILD stock, worth $7.87 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

94,187

Previous 61,180 53.95%

Holding current value

$7.87 Million

Previous $4.48 Million 44.21%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $2.08 Million - $2.41 Million	33,007 Added 53.95%	94,187 $6.46 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $452,099 - $551,323	6,316 Added 11.51%	61,180 $4.48 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $513,402 - $582,211	7,007 Added 14.64%	54,864 $4.44 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $622,352 - $678,999	8,417 Added 21.34%	47,857 $3.59 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $212,675 - $242,586	-2,798 Reduced 6.62%	39,440 $3.04 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $3.19 Million - $3.63 Million	-41,261 Reduced 49.41%	42,238 $3.5 Million
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $581,944 - $835,470	9,338 Added 12.59%	83,499 $7.17 Million
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $392,070 - $447,845	6,585 Added 9.74%	74,161 $4.58 Billion
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $952,033 - $1.07 Million	16,494 Added 32.29%	67,576 $4.18 Million
Q1 2022 Apr 26, 2022	SELL	$57.92 - $72.58 $1.42 Million - $1.78 Million	-24,530 Reduced 32.44%	51,082 $3.04 Million
Q4 2021 Jan 20, 2022	BUY	$64.88 - $73.64 $140,205 - $159,136	2,161 Added 2.94%	75,612 $5.49 Million
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $1.26 Million - $1.35 Million	18,542 Added 33.77%	73,451 $5.13 Million
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $83,145 - $90,848	1,310 Added 2.44%	54,909 $3.78 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $87,600 - $99,951	1,460 Added 2.8%	53,599 $3.46 Million
Q4 2020 Jan 20, 2021	BUY	$56.65 - $64.55 $440,170 - $501,553	7,770 Added 17.51%	52,139 $2.95 Billion
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $2.76 Million - $3.46 Million	44,369 New	44,369 $2.81 Billion

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Gilead Sciences, Inc. Transaction History